SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tim Luke who wrote (4349)12/30/1998 9:18:00 PM
From: EaglePutt  Read Replies (2) of 90042
 
LIPO, this one is good solid biotech that I trade for a while in November.
I expect this one to be in the 30'2 very shortly pending FDA approval of two drugs.

I would also like to bring to your attention MTC and PFE. I have heard from several sources that Celebrex is to be approved by FDA soon and todays action looks awfully suspicious. The drug was developed by MTC and is being marketed by PFE sales force. I have taken a position in MTC; a 15 point run-up would not surprise me. Several experts are expecting the Celebrex market to be as good as the Viagra market. I have been waiting for this one for a really long time.

Good luck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext